Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Feb;67(2):341–346. doi: 10.1038/bjc.1993.62

A daily diary for quality of life measurement in advanced breast cancer trials.

S C Fraser 1, A J Ramirez 1, S R Ebbs 1, L J Fallowfield 1, H J Dobbs 1, M A Richards 1, T Bates 1, M Baum 1
PMCID: PMC1968179  PMID: 8431363

Abstract

The Qualitator is a daily diary card to measure Quality of Life, developed for use in chemotherapy trials for patients with advanced breast cancer. In a trial at King's College Hospital, 29 patients completed the Qualitator and their scores were compared with scores in the Linear Analogue Self-Assessment and Nottingham Health Profile taken four-weekly. In a separate study at Guy's Hospital, 31 patients completed the diary. The Qualitator offers accurate prognostic data regarding subsequent UICC response and survival and is simple to use.

Full text

PDF
341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A'Hern R. P., Ebbs S. R., Baum M. B. Does chemotherapy improve survival in advanced breast cancer? A statistical overview. Br J Cancer. 1988 Jun;57(6):615–618. doi: 10.1038/bjc.1988.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aaronson N. K. Quantitative issues in health-related quality of life assessment. Health Policy. 1988;10(3):217–230. doi: 10.1016/0168-8510(88)90058-9. [DOI] [PubMed] [Google Scholar]
  3. Addington-Hall J. M., MacDonald L. D., Anderson H. R. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer. 1990 Oct;62(4):695–699. doi: 10.1038/bjc.1990.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baum M., Priestman T., West R. R., Jones E. M. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer. 1980;Suppl 1:223–226. [PubMed] [Google Scholar]
  5. Bergner M. Quality of life, health status, and clinical research. Med Care. 1989 Mar;27(3 Suppl):S148–S156. doi: 10.1097/00005650-198903001-00012. [DOI] [PubMed] [Google Scholar]
  6. Boyd N. F., Selby P. J., Sutherland H. J., Hogg S. Measurement of the clinical status of patients with breast cancer: evidence for the validity of self assessment with linear analogue scales. J Clin Epidemiol. 1988;41(3):243–250. doi: 10.1016/0895-4356(88)90128-x. [DOI] [PubMed] [Google Scholar]
  7. Clement-Jones V. Cancer and beyond: the formation of BACUP. Br Med J (Clin Res Ed) 1985 Oct 12;291(6501):1021–1023. doi: 10.1136/bmj.291.6501.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ebbs S. R., Saunders J. A., Graham H., A'Hern R. P., Bates T., Baum M. Advanced breast cancer. A randomised trial of epidoxorubicin at two different dosages and two administration systems. Acta Oncol. 1989;28(6):887–892. doi: 10.3109/02841868909092326. [DOI] [PubMed] [Google Scholar]
  9. Fraser S. C., Ebbs S. R., Dobbs H. J., Fallowfield L. J., Baum M. The design of advanced breast cancer trials. New approaches. Acta Oncol. 1990;29(3):397–400. doi: 10.3109/02841869009090021. [DOI] [PubMed] [Google Scholar]
  10. Geddes D. M., Dones L., Hill E., Law K., Harper P. G., Spiro S. G., Tobias J. S., Souhami R. L. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer. 1990 Apr;26(4):484–492. doi: 10.1016/0277-5379(90)90022-l. [DOI] [PubMed] [Google Scholar]
  11. Guyatt G. H., Bombardier C., Tugwell P. X. Measuring disease-specific quality of life in clinical trials. CMAJ. 1986 Apr 15;134(8):889–895. [PMC free article] [PubMed] [Google Scholar]
  12. Hunt S. M., McEwen J., McKenna S. P. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract. 1985 Apr;35(273):185–188. [PMC free article] [PubMed] [Google Scholar]
  13. Maguire P., Selby P. Assessing quality of life in cancer patients. Br J Cancer. 1989 Sep;60(3):437–440. doi: 10.1038/bjc.1989.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morris J. N., Sherwood S. Quality of life of cancer patients at different stages in the disease trajectory. J Chronic Dis. 1987;40(6):545–556. doi: 10.1016/0021-9681(87)90012-9. [DOI] [PubMed] [Google Scholar]
  15. Priestman T. J., Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet. 1976 Apr 24;1(7965):899–900. doi: 10.1016/s0140-6736(76)92112-7. [DOI] [PubMed] [Google Scholar]
  16. Richards M. A., Hopwood P., Ramirez A. J., Twelves C. J., Ferguson J., Gregory W. M., Swindell R., Scrivener W., Miller J., Howell A. Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life. Eur J Cancer. 1992;28A(6-7):1023–1028. doi: 10.1016/0959-8049(92)90447-a. [DOI] [PubMed] [Google Scholar]
  17. Slevin M. L., Plant H., Lynch D., Drinkwater J., Gregory W. M. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988 Jan;57(1):109–112. doi: 10.1038/bjc.1988.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ware J. E., Jr Standards for validating health measures: definition and content. J Chronic Dis. 1987;40(6):473–480. doi: 10.1016/0021-9681(87)90003-8. [DOI] [PubMed] [Google Scholar]
  19. de Haes J. C., van Knippenberg F. C., Neijt J. P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990 Dec;62(6):1034–1038. doi: 10.1038/bjc.1990.434. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES